N

Nightingale Health Oyj
F:7XE

Watchlist Manager
Nightingale Health Oyj
F:7XE
Watchlist
Price: 1.926 EUR -2.03% Market Closed
Market Cap: 119.9m EUR

Wall Street
Price Targets

7XE Price Targets Summary
Nightingale Health Oyj

Wall Street analysts forecast 7XE stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 7XE is 1.7 EUR with a low forecast of 0.962 EUR and a high forecast of 2.501 EUR.

Lowest
Price Target
0.962 EUR
50% Downside
Average
Price Target
1.7 EUR
12% Downside
Highest
Price Target
2.501 EUR
30% Upside
Nightingale Health Oyj Competitors:
Price Targets
THYROCARE
Thyrocare Technologies Ltd
27% Upside
CSTL
Castle Biosciences Inc
4% Downside
PINC
Premier Inc
45% Upside
OPCH
Option Care Health Inc
14% Upside
IDHC
Integrated Diagnostics Holdings PLC
17% Upside
HIMS
Hims & Hers Health Inc
34% Upside

Revenue
Forecast

Revenue Estimate
Nightingale Health Oyj

For the last 7 years the compound annual growth rate for Nightingale Health Oyj's revenue is 15%. The projected CAGR for the next 3 years is 37%.

15%
Past Growth
37%
Estimated Growth
Estimates Accuracy
-28%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Nightingale Health Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Nightingale Health Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 7XE's stock price target?
Price Target
1.7 EUR

According to Wall Street analysts, the average 1-year price target for 7XE is 1.7 EUR with a low forecast of 0.962 EUR and a high forecast of 2.501 EUR.

What is Nightingale Health Oyj's Revenue forecast?
Projected CAGR
37%

For the last 7 years the compound annual growth rate for Nightingale Health Oyj's revenue is 15%. The projected CAGR for the next 3 years is 37%.

Back to Top